Endothelin receptors, specifically ETA and ETB, are class A G protein-coupled receptors (GPCRs) that are activated by the vasoactive peptide endothelins and play a role in blood pressure regulation. Selective signaling through the ETB receptor induces vasorelaxation, making selective ETB agonists potential candidates for improved anti-tumor drug delivery and neuroprotection.